[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053231":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":34,"responsibleParty":255,"collaborators":25,"id":257,"slug":25,"hasResults":258,"nctId":259,"briefTitle":260,"officialTitle":261,"acronym":25,"eligibilityCriteria":262,"healthyVolunteers":258,"sex":263,"minAge":264,"maxAge":25,"enrollmentInfo":265,"targetDuration":25,"studyType":268,"phases":269,"briefSummary":271,"conditions":272,"keywords":274,"overallStatus":37,"whyStopped":25,"lastUpdateSubmitDate":279,"lastUpdatePostDateStruct":280,"startDateStruct":283,"completionDateStruct":285,"leadSponsor":287,"locationsCount":288},{"fullName":5,"class":6},"Akebia Therapeutics","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Praliciguat","EXPERIMENTAL","Praliciguat will be administered daily with dose escalation to a target dose during a 24-week double-blind period, followed by a 24-week open-label treatment period.",[13],"Drug: Praliciguat",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Matching placebo will be administered daily for 24 weeks",[19],"Other: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Oral Tablet",[9],null,{"type":27,"name":15,"description":23,"armGroupLabels":28,"otherNames":25},"OTHER",[15],[30],{"name":5,"role":31,"phone":32,"phoneExt":25,"email":33},"CONTACT","16178446128","trials@akebia.com",[35,48,57,66,76,86,95,104,113,123,134,144,154,163,173,183,193,202,212,222,232,241,247],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":25},"Investigator Site #2","RECRUITING","Chula Vista","California","91910","United States",{"type":43,"coordinates":44},"Point",[45,46],-117.0842,32.64005,{"lat":46,"lon":45},{"facility":49,"status":37,"city":50,"state":39,"zip":51,"country":41,"cosmosGeoPoint":52,"geoPoint":56,"contacts":25},"Investigator Site #14","Los Angeles","90022",{"type":43,"coordinates":53},[54,55],-118.24368,34.05223,{"lat":55,"lon":54},{"facility":58,"status":37,"city":59,"state":39,"zip":60,"country":41,"cosmosGeoPoint":61,"geoPoint":65,"contacts":25},"Investigator Site #12","San Dimas","91773",{"type":43,"coordinates":62},[63,64],-117.80673,34.10668,{"lat":64,"lon":63},{"facility":67,"status":37,"city":68,"state":69,"zip":70,"country":41,"cosmosGeoPoint":71,"geoPoint":75,"contacts":25},"Investigator Site #13","Arvada","Colorado","80002",{"type":43,"coordinates":72},[73,74],-105.08748,39.80276,{"lat":74,"lon":73},{"facility":77,"status":37,"city":78,"state":79,"zip":80,"country":41,"cosmosGeoPoint":81,"geoPoint":85,"contacts":25},"Investigator Site #17","Boca Raton","Florida","33431",{"type":43,"coordinates":82},[83,84],-80.0831,26.35869,{"lat":84,"lon":83},{"facility":87,"status":37,"city":88,"state":79,"zip":89,"country":41,"cosmosGeoPoint":90,"geoPoint":94,"contacts":25},"Investigator Site #6","Coral Springs","33071",{"type":43,"coordinates":91},[92,93],-80.2706,26.27119,{"lat":93,"lon":92},{"facility":96,"status":37,"city":97,"state":79,"zip":98,"country":41,"cosmosGeoPoint":99,"geoPoint":103,"contacts":25},"Investigator Site #7","Miami","33172",{"type":43,"coordinates":100},[101,102],-80.19366,25.77427,{"lat":102,"lon":101},{"facility":105,"status":37,"city":106,"state":79,"zip":107,"country":41,"cosmosGeoPoint":108,"geoPoint":112,"contacts":25},"Investigator Site #8","Orlando","32806",{"type":43,"coordinates":109},[110,111],-81.37924,28.53834,{"lat":111,"lon":110},{"facility":114,"status":37,"city":115,"state":116,"zip":117,"country":41,"cosmosGeoPoint":118,"geoPoint":122,"contacts":25},"Investigator Site # 1","Lawrenceville","Georgia","30046",{"type":43,"coordinates":119},[120,121],-83.98796,33.95621,{"lat":121,"lon":120},{"facility":124,"status":125,"city":126,"state":127,"zip":128,"country":41,"cosmosGeoPoint":129,"geoPoint":133,"contacts":25},"Investigator Site #3","TERMINATED","Chicago","Illinois","60643",{"type":43,"coordinates":130},[131,132],-87.65005,41.85003,{"lat":132,"lon":131},{"facility":135,"status":37,"city":136,"state":137,"zip":138,"country":41,"cosmosGeoPoint":139,"geoPoint":143,"contacts":25},"Investigator Site #11","Louisville","Kentucky","40205",{"type":43,"coordinates":140},[141,142],-85.75941,38.25424,{"lat":142,"lon":141},{"facility":145,"status":37,"city":146,"state":147,"zip":148,"country":41,"cosmosGeoPoint":149,"geoPoint":153,"contacts":25},"Investigator Site #15","Livonia","Michigan","48152",{"type":43,"coordinates":150},[151,152],-83.35271,42.36837,{"lat":152,"lon":151},{"facility":155,"status":37,"city":156,"state":147,"zip":157,"country":41,"cosmosGeoPoint":158,"geoPoint":162,"contacts":25},"Investigator Site #10","Pontiac","48341",{"type":43,"coordinates":159},[160,161],-83.29105,42.63892,{"lat":161,"lon":160},{"facility":164,"status":37,"city":165,"state":166,"zip":167,"country":41,"cosmosGeoPoint":168,"geoPoint":172,"contacts":25},"Investigator Site #16","New Bern","North Carolina","28562",{"type":43,"coordinates":169},[170,171],-77.04411,35.10849,{"lat":171,"lon":170},{"facility":174,"status":37,"city":175,"state":176,"zip":177,"country":41,"cosmosGeoPoint":178,"geoPoint":182,"contacts":25},"Investigator Site #20","Cleveland","Ohio","44106",{"type":43,"coordinates":179},[180,181],-81.69541,41.4995,{"lat":181,"lon":180},{"facility":184,"status":37,"city":185,"state":186,"zip":187,"country":41,"cosmosGeoPoint":188,"geoPoint":192,"contacts":25},"Investigator Site #19","Bridgeville","Pennsylvania","15017",{"type":43,"coordinates":189},[190,191],-80.11006,40.35618,{"lat":191,"lon":190},{"facility":194,"status":37,"city":195,"state":186,"zip":196,"country":41,"cosmosGeoPoint":197,"geoPoint":201,"contacts":25},"Investigator Site #22","Butler","16001",{"type":43,"coordinates":198},[199,200],-79.89533,40.86118,{"lat":200,"lon":199},{"facility":203,"status":37,"city":204,"state":205,"zip":206,"country":41,"cosmosGeoPoint":207,"geoPoint":211,"contacts":25},"Investigator Site #23","Goose Creek","South Carolina","29445",{"type":43,"coordinates":208},[209,210],-80.03259,32.98101,{"lat":210,"lon":209},{"facility":213,"status":37,"city":214,"state":215,"zip":216,"country":41,"cosmosGeoPoint":217,"geoPoint":221,"contacts":25},"Investigator Site #4","Chattanooga","Tennessee","37404",{"type":43,"coordinates":218},[219,220],-85.30968,35.04563,{"lat":220,"lon":219},{"facility":223,"status":37,"city":224,"state":225,"zip":226,"country":41,"cosmosGeoPoint":227,"geoPoint":231,"contacts":25},"Investigator Site #5","Arlington","Texas","76015",{"type":43,"coordinates":228},[229,230],-97.10807,32.73569,{"lat":230,"lon":229},{"facility":233,"status":37,"city":234,"state":225,"zip":235,"country":41,"cosmosGeoPoint":236,"geoPoint":240,"contacts":25},"Investigator Site #21","Dallas","75230",{"type":43,"coordinates":237},[238,239],-96.80667,32.78306,{"lat":239,"lon":238},{"facility":242,"status":37,"city":234,"state":225,"zip":243,"country":41,"cosmosGeoPoint":244,"geoPoint":246,"contacts":25},"Investigator Site #9","75231",{"type":43,"coordinates":245},[238,239],{"lat":239,"lon":238},{"facility":248,"status":37,"city":249,"state":225,"zip":148,"country":41,"cosmosGeoPoint":250,"geoPoint":254,"contacts":25},"Investigator Site #18","Houston",{"type":43,"coordinates":251},[252,253],-95.36327,29.76328,{"lat":253,"lon":252},{"type":256,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100053231",false,"NCT07268638","A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)","A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Praliciguat in Patients With Biopsy-Confirmed Focal Segmental Glomerulosclerosis","Inclusion Criteria:\n\n1. UPCR ≥1 (g\u002Fg) during screening.\n2. On maximally tolerated ACEi or ARB per principal investigator discretion within 1 month of informed consent.\n3. Estimated glomerular filtration rate ≥25 milliliters per minute per 1.73 square meters by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.\n4. Kidney biopsy collected within 5 years of screening consistent with FSGS or kidney biopsy collected ≥5 years prior to screening consistent with FSGS plus the presence of a pathogenic gene mutation known to be associated with FSGS.\n\nExclusion Criteria:\n\n1. Collapsing FSGS in the kidney biopsy report.\n2. Sickle cell disease.\n3. HbA1c \\>8%.\n4. Uncontrolled hypertension (≥160\u002F100 millimeters of mercury).","ALL","18 Years",{"count":266,"type":267},60,"ESTIMATED","INTERVENTIONAL",[270],"PHASE2","This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study designed to evaluate the efficacy and safety of praliciguat in adults with biopsy-confirmed focal segmental glomerulosclerosis (FSGS). Participants will be randomized 1:1 to receive praliciguat or placebo for initial 24 week treatment period. Following this double-blind period, all participants will receive praliciguat in an open-label extension for an additional 24 weeks.",[273],"Focal Segmental Glomerulosclerosis",[275,276,277,278],"Glomerular Disease","Chronic Kidney Disease","Proteinuria","Urine protein-to-creatinine ratio","2026-07-10",{"date":281,"type":282},"2026-07-13","ACTUAL",{"date":284,"type":282},"2025-12-03",{"date":286,"type":267},"2028-01",{"name":5,"class":6},23]